Form4insider filings, from the source

SEC Form 4 · accession 0001144204-15-018080

CORCEPT THERAPEUTICS INC · CORT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Patrick G Enright
Director · 10% Owner
Period of report
Mar 20, 2015
Accepted (ET)
Mar 24, 2015 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Mar 20, 2015X634,516$2.77A13,145,097IBy LVP
Common StockF1Mar 20, 2015S300,447$5.85D12,844,650IBy LVP
Common StockF1Mar 20, 2015X486,443$2.77A13,331,093IBy LVP
Common StockF1Mar 20, 2015S230,333$5.85D13,100,760IBy LVP
Common StockF4Mar 20, 2015X9,750$2.77A182,742IBy LCA
Common StockF4Mar 20, 2015S4,617$5.85D178,125IBy LCA
Common StockF1Mar 24, 2015X1,130,709$2.77A14,231,469IBy LVP
Common StockF1Mar 24, 2015S554,348$5.65D13,677,121IBy LVP

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Warrant (Right to Buy)F1$2.77Mar 20, 2015X634,516DMar 25, 2008Mar 24, 2015Common Stock634,5161,130,709I
Warrant (Right to Buy)F1$2.77Mar 20, 2015X486,443DFeb 6, 2009Mar 24, 2015Common Stock486,4430I
Warrant (Right to Buy)F4$2.77Mar 20, 2015X9,750DFeb 6, 2009Mar 24, 2015Common Stock9,7500I
Warrant (Right to Buy)F1$2.77Mar 24, 2015X1,130,709DMar 25, 2008Mar 24, 2015Common Stock1,130,7090I

Explanation of responses